| Literature DB >> 29802036 |
Thomas Colunga1, Stephen Dalton2.
Abstract
Vascular progenitor cells have been identified from perivascular cell fractions and peripheral blood and bone marrow mononuclear fractions. These vascular progenitors share the ability to generate some of the vascular lineages, including endothelial cells, smooth muscle cells, and pericytes. The potential therapeutic uses for vascular progenitor cells are broad and relate to stroke, ischemic disease, and to the engineering of whole organs and tissues that require a vascular component. This review summarizes the best-characterized sources of vascular progenitor cells and discusses advances in 3D printing and electrospinning using blended polymers for the creation of biomimetic vascular grafts. These advances are pushing the field of regenerative medicine closer to the creation of small-diameter vascular grafts with long-term clinical utility.Entities:
Keywords: cell therapy; tissue engineering; vascular progenitor cells
Mesh:
Year: 2018 PMID: 29802036 PMCID: PMC6050017 DOI: 10.1016/j.molmed.2018.05.002
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951